 Global Supplement for Menopause Market Growth 2026-2032
The global Supplement for Menopause market size is predicted to grow from US$ 1794 million in 2025 to US$ 3296 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032. Suppleme... もっと見る
SummaryThe global Supplement for Menopause market size is predicted to grow from US$ 1794 million in 2025 to US$ 3296 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032.Supplement for Menopause is a dietary supplement product designed to relieve the physical and psychological discomfort symptoms caused by ovarian dysfunction, fluctuations or decreases in estrogen levels in women during menopause. It usually uses natural plant extracts (such as soy isoflavones, black cohosh, and pomegranate flavonoids), vitamins (such as vitamin D and B vitamins), minerals (such as calcium, magnesium, and zinc), probiotics (such as specific strains that regulate the intestinal-estrogen axis), and Omega-3 fatty acids as core ingredients. Through scientific proportions, it simulates or supports hormone balance in the body, strengthens bone health, improves nerve conduction function, regulates mood and antioxidant defense system, and aims to help menopausal women smoothly pass through the physiological transition period of drastic hormone fluctuations and reduce osteoporosis, cardiovascular disease, cognitive decline, etc. The global market for Supplement for Menopause is welcoming multiple development opportunities and significant trends. With the acceleration of global population aging, it is estimated that by 2030, more than 1.2 billion women will enter menopause worldwide, with more than 200 million menopausal women in China alone. The huge consumer group has laid a solid foundation for market growth. At the same time, women's health awareness has significantly improved, and more than 80% of menopausal women experience discomfort symptoms. The demand for relieving hot flashes, insomnia, osteoporosis and other problems has driven market expansion. From the trend point of view, innovation in natural ingredients has become the core direction. Ingredients such as phytoestrogens (such as soy isoflavones, pomegranate flavonoids), collagen peptides, and Omega-3 fatty acids are favored. Clinical trials have confirmed that they can improve bone density, skin elasticity and cardiovascular health. The integration of personalization and technology is accelerating. The AI-driven nutrition system integrates blood indicators, diet records and other data to provide daily nutrition recommendations; wearable devices monitor heart rate variability and sleep quality to assist in the management of menopausal symptoms. In addition, the market is segmented and differentiated in competition. Women in first-tier cities prefer high-end medical services and digital tools, while lower-tier cities rely on doctor recommendations and cost-effective products. Companies need to optimize channels and marketing strategies for different levels. Overall, the Supplement for Menopause market will continue to expand driven by demand, policy guidance and technological innovation. LP Information, Inc. (LPI) ' newest research report, the “Supplement for Menopause Industry Forecast” looks at past sales and reviews total world Supplement for Menopause sales in 2025, providing a comprehensive analysis by region and market sector of projected Supplement for Menopause sales for 2026 through 2032. With Supplement for Menopause sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Supplement for Menopause industry. This Insight Report provides a comprehensive analysis of the global Supplement for Menopause landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Supplement for Menopause portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Supplement for Menopause market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Supplement for Menopause and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Supplement for Menopause. This report presents a comprehensive overview, market shares, and growth opportunities of Supplement for Menopause market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Hormone Regulation Supplements Bone Health Supplements Cardiovascular and Metabolic Support Supplements Mood and Sleep Regulation Supplements Others Segmentation by Application: Online Pharmacies Retail Pharmacies Hospital This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. AdvaCare Pharma Amerifit Brands (Estroven) Biofarma Group Bonafide Health Equelle Flourish GNC Kobayashi Pharmaceutical Makers Nutrition Menoelle MenoLabs Menopace New Nordic Nordic Naturals Otsuka Pharmaceutical PharmaLinea PhytoLife Pharma Promensil SMPNutra The Better Menopause Vitabiotics Key Questions Addressed in this Report What is the 10-year outlook for the global Supplement for Menopause market? What factors are driving Supplement for Menopause market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Supplement for Menopause market opportunities vary by end market size? How does Supplement for Menopause break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Supplement for Menopause Annual Sales 2021-2032 2.1.2 World Current & Future Analysis for Supplement for Menopause by Geographic Region, 2021, 2025 & 2032 2.1.3 World Current & Future Analysis for Supplement for Menopause by Country/Region, 2021, 2025 & 2032 2.2 Supplement for Menopause Segment by Type 2.2.1 Hormone Regulation Supplements 2.2.2 Bone Health Supplements 2.2.3 Cardiovascular and Metabolic Support Supplements 2.2.4 Mood and Sleep Regulation Supplements 2.2.5 Others 2.2.6 Supplement for Menopause Sales by Type 2.2.6.1 Global Supplement for Menopause Sales Market Share by Type (2021-2026) 2.2.6.2 Global Supplement for Menopause Revenue and Market Share by Type (2021-2026) 2.2.6.3 Global Supplement for Menopause Sale Price by Type (2021-2026) 2.3 Supplement for Menopause Segment by Application 2.3.1 Online Pharmacies 2.3.2 Retail Pharmacies 2.3.3 Hospital 2.3.4 Supplement for Menopause Sales by Application 2.3.4.1 Global Supplement for Menopause Sale Market Share by Application (2021-2026) 2.3.4.2 Global Supplement for Menopause Revenue and Market Share by Application (2021-2026) 2.3.4.3 Global Supplement for Menopause Sale Price by Application (2021-2026) 3 Global by Company 3.1 Global Supplement for Menopause Breakdown Data by Company 3.1.1 Global Supplement for Menopause Annual Sales by Company (2021-2026) 3.1.2 Global Supplement for Menopause Sales Market Share by Company (2021-2026) 3.2 Global Supplement for Menopause Annual Revenue by Company (2021-2026) 3.2.1 Global Supplement for Menopause Revenue by Company (2021-2026) 3.2.2 Global Supplement for Menopause Revenue Market Share by Company (2021-2026) 3.3 Global Supplement for Menopause Sale Price by Company 3.4 Key Manufacturers Supplement for Menopause Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Supplement for Menopause Product Location Distribution 3.4.2 Players Supplement for Menopause Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Supplement for Menopause by Geographic Region 4.1 World Historic Supplement for Menopause Market Size by Geographic Region (2021-2026) 4.1.1 Global Supplement for Menopause Annual Sales by Geographic Region (2021-2026) 4.1.2 Global Supplement for Menopause Annual Revenue by Geographic Region (2021-2026) 4.2 World Historic Supplement for Menopause Market Size by Country/Region (2021-2026) 4.2.1 Global Supplement for Menopause Annual Sales by Country/Region (2021-2026) 4.2.2 Global Supplement for Menopause Annual Revenue by Country/Region (2021-2026) 4.3 Americas Supplement for Menopause Sales Growth 4.4 APAC Supplement for Menopause Sales Growth 4.5 Europe Supplement for Menopause Sales Growth 4.6 Middle East & Africa Supplement for Menopause Sales Growth 5 Americas 5.1 Americas Supplement for Menopause Sales by Country 5.1.1 Americas Supplement for Menopause Sales by Country (2021-2026) 5.1.2 Americas Supplement for Menopause Revenue by Country (2021-2026) 5.2 Americas Supplement for Menopause Sales by Type (2021-2026) 5.3 Americas Supplement for Menopause Sales by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Supplement for Menopause Sales by Region 6.1.1 APAC Supplement for Menopause Sales by Region (2021-2026) 6.1.2 APAC Supplement for Menopause Revenue by Region (2021-2026) 6.2 APAC Supplement for Menopause Sales by Type (2021-2026) 6.3 APAC Supplement for Menopause Sales by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Supplement for Menopause by Country 7.1.1 Europe Supplement for Menopause Sales by Country (2021-2026) 7.1.2 Europe Supplement for Menopause Revenue by Country (2021-2026) 7.2 Europe Supplement for Menopause Sales by Type (2021-2026) 7.3 Europe Supplement for Menopause Sales by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Supplement for Menopause by Country 8.1.1 Middle East & Africa Supplement for Menopause Sales by Country (2021-2026) 8.1.2 Middle East & Africa Supplement for Menopause Revenue by Country (2021-2026) 8.2 Middle East & Africa Supplement for Menopause Sales by Type (2021-2026) 8.3 Middle East & Africa Supplement for Menopause Sales by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Supplement for Menopause 10.3 Manufacturing Process Analysis of Supplement for Menopause 10.4 Industry Chain Structure of Supplement for Menopause 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Supplement for Menopause Distributors 11.3 Supplement for Menopause Customer 12 World Forecast Review for Supplement for Menopause by Geographic Region 12.1 Global Supplement for Menopause Market Size Forecast by Region 12.1.1 Global Supplement for Menopause Forecast by Region (2027-2032) 12.1.2 Global Supplement for Menopause Annual Revenue Forecast by Region (2027-2032) 12.2 Americas Forecast by Country (2027-2032) 12.3 APAC Forecast by Region (2027-2032) 12.4 Europe Forecast by Country (2027-2032) 12.5 Middle East & Africa Forecast by Country (2027-2032) 12.6 Global Supplement for Menopause Forecast by Type (2027-2032) 12.7 Global Supplement for Menopause Forecast by Application (2027-2032) 13 Key Players Analysis 13.1 AdvaCare Pharma 13.1.1 AdvaCare Pharma Company Information 13.1.2 AdvaCare Pharma Supplement for Menopause Product Portfolios and Specifications 13.1.3 AdvaCare Pharma Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.1.4 AdvaCare Pharma Main Business Overview 13.1.5 AdvaCare Pharma Latest Developments 13.2 Amerifit Brands (Estroven) 13.2.1 Amerifit Brands (Estroven) Company Information 13.2.2 Amerifit Brands (Estroven) Supplement for Menopause Product Portfolios and Specifications 13.2.3 Amerifit Brands (Estroven) Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.2.4 Amerifit Brands (Estroven) Main Business Overview 13.2.5 Amerifit Brands (Estroven) Latest Developments 13.3 Biofarma Group 13.3.1 Biofarma Group Company Information 13.3.2 Biofarma Group Supplement for Menopause Product Portfolios and Specifications 13.3.3 Biofarma Group Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.3.4 Biofarma Group Main Business Overview 13.3.5 Biofarma Group Latest Developments 13.4 Bonafide Health 13.4.1 Bonafide Health Company Information 13.4.2 Bonafide Health Supplement for Menopause Product Portfolios and Specifications 13.4.3 Bonafide Health Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.4.4 Bonafide Health Main Business Overview 13.4.5 Bonafide Health Latest Developments 13.5 Equelle 13.5.1 Equelle Company Information 13.5.2 Equelle Supplement for Menopause Product Portfolios and Specifications 13.5.3 Equelle Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.5.4 Equelle Main Business Overview 13.5.5 Equelle Latest Developments 13.6 Flourish 13.6.1 Flourish Company Information 13.6.2 Flourish Supplement for Menopause Product Portfolios and Specifications 13.6.3 Flourish Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.6.4 Flourish Main Business Overview 13.6.5 Flourish Latest Developments 13.7 GNC 13.7.1 GNC Company Information 13.7.2 GNC Supplement for Menopause Product Portfolios and Specifications 13.7.3 GNC Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.7.4 GNC Main Business Overview 13.7.5 GNC Latest Developments 13.8 Kobayashi Pharmaceutical 13.8.1 Kobayashi Pharmaceutical Company Information 13.8.2 Kobayashi Pharmaceutical Supplement for Menopause Product Portfolios and Specifications 13.8.3 Kobayashi Pharmaceutical Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.8.4 Kobayashi Pharmaceutical Main Business Overview 13.8.5 Kobayashi Pharmaceutical Latest Developments 13.9 Makers Nutrition 13.9.1 Makers Nutrition Company Information 13.9.2 Makers Nutrition Supplement for Menopause Product Portfolios and Specifications 13.9.3 Makers Nutrition Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.9.4 Makers Nutrition Main Business Overview 13.9.5 Makers Nutrition Latest Developments 13.10 Menoelle 13.10.1 Menoelle Company Information 13.10.2 Menoelle Supplement for Menopause Product Portfolios and Specifications 13.10.3 Menoelle Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.10.4 Menoelle Main Business Overview 13.10.5 Menoelle Latest Developments 13.11 MenoLabs 13.11.1 MenoLabs Company Information 13.11.2 MenoLabs Supplement for Menopause Product Portfolios and Specifications 13.11.3 MenoLabs Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.11.4 MenoLabs Main Business Overview 13.11.5 MenoLabs Latest Developments 13.12 Menopace 13.12.1 Menopace Company Information 13.12.2 Menopace Supplement for Menopause Product Portfolios and Specifications 13.12.3 Menopace Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.12.4 Menopace Main Business Overview 13.12.5 Menopace Latest Developments 13.13 New Nordic 13.13.1 New Nordic Company Information 13.13.2 New Nordic Supplement for Menopause Product Portfolios and Specifications 13.13.3 New Nordic Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.13.4 New Nordic Main Business Overview 13.13.5 New Nordic Latest Developments 13.14 Nordic Naturals 13.14.1 Nordic Naturals Company Information 13.14.2 Nordic Naturals Supplement for Menopause Product Portfolios and Specifications 13.14.3 Nordic Naturals Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.14.4 Nordic Naturals Main Business Overview 13.14.5 Nordic Naturals Latest Developments 13.15 Otsuka Pharmaceutical 13.15.1 Otsuka Pharmaceutical Company Information 13.15.2 Otsuka Pharmaceutical Supplement for Menopause Product Portfolios and Specifications 13.15.3 Otsuka Pharmaceutical Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.15.4 Otsuka Pharmaceutical Main Business Overview 13.15.5 Otsuka Pharmaceutical Latest Developments 13.16 PharmaLinea 13.16.1 PharmaLinea Company Information 13.16.2 PharmaLinea Supplement for Menopause Product Portfolios and Specifications 13.16.3 PharmaLinea Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.16.4 PharmaLinea Main Business Overview 13.16.5 PharmaLinea Latest Developments 13.17 PhytoLife Pharma 13.17.1 PhytoLife Pharma Company Information 13.17.2 PhytoLife Pharma Supplement for Menopause Product Portfolios and Specifications 13.17.3 PhytoLife Pharma Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.17.4 PhytoLife Pharma Main Business Overview 13.17.5 PhytoLife Pharma Latest Developments 13.18 Promensil 13.18.1 Promensil Company Information 13.18.2 Promensil Supplement for Menopause Product Portfolios and Specifications 13.18.3 Promensil Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.18.4 Promensil Main Business Overview 13.18.5 Promensil Latest Developments 13.19 SMPNutra 13.19.1 SMPNutra Company Information 13.19.2 SMPNutra Supplement for Menopause Product Portfolios and Specifications 13.19.3 SMPNutra Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.19.4 SMPNutra Main Business Overview 13.19.5 SMPNutra Latest Developments 13.20 The Better Menopause 13.20.1 The Better Menopause Company Information 13.20.2 The Better Menopause Supplement for Menopause Product Portfolios and Specifications 13.20.3 The Better Menopause Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.20.4 The Better Menopause Main Business Overview 13.20.5 The Better Menopause Latest Developments 13.21 Vitabiotics 13.21.1 Vitabiotics Company Information 13.21.2 Vitabiotics Supplement for Menopause Product Portfolios and Specifications 13.21.3 Vitabiotics Supplement for Menopause Sales, Revenue, Price and Gross Margin (2021-2026) 13.21.4 Vitabiotics Main Business Overview 13.21.5 Vitabiotics Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Supplement for Menopause Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Supplement for Menopause Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Hormone Regulation Supplements Table 4. Major Players of Bone Health Supplements Table 5. Major Players of Cardiovascular and Metabolic Support Supplements Table 6. Major Players of Mood and Sleep Regulation Supplements Table 7. Major Players of Others Table 8. Global Supplement for Menopause Sales by Type (2021-2026) & (K Units) Table 9. Global Supplement for Menopause Sales Market Share by Type (2021-2026) Table 10. Global Supplement for Menopause Revenue by Type (2021-2026) & ($ million) Table 11. Global Supplement for Menopause Revenue Market Share by Type (2021-2026) Table 12. Global Supplement for Menopause Sale Price by Type (2021-2026) & (US$/Unit) Table 13. Global Supplement for Menopause Sale by Application (2021-2026) & (K Units) Table 14. Global Supplement for Menopause Sale Market Share by Application (2021-2026) Table 15. Global Supplement for Menopause Revenue by Application (2021-2026) & ($ million) Table 16. Global Supplement for Menopause Revenue Market Share by Application (2021-2026) Table 17. Global Supplement for Menopause Sale Price by Application (2021-2026) & (US$/Unit) Table 18. Global Supplement for Menopause Sales by Company (2021-2026) & (K Units) Table 19. Global Supplement for Menopause Sales Market Share by Company (2021-2026) Table 20. Global Supplement for Menopause Revenue by Company (2021-2026) & ($ millions) Table 21. Global Supplement for Menopause Revenue Market Share by Company (2021-2026) Table 22. Global Supplement for Menopause Sale Price by Company (2021-2026) & (US$/Unit) Table 23. Key Manufacturers Supplement for Menopause Producing Area Distribution and Sales Area Table 24. Players Supplement for Menopause Products Offered Table 25. Supplement for Menopause Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 26. New Products and Potential Entrants Table 27. Market M&A Activity & Strategy Table 28. Global Supplement for Menopause Sales by Geographic Region (2021-2026) & (K Units) Table 29. Global Supplement for Menopause Sales Market Share Geographic Region (2021-2026) Table 30. Global Supplement for Menopause Revenue by Geographic Region (2021-2026) & ($ millions) Table 31. Global Supplement for Menopause Revenue Market Share by Geographic Region (2021-2026) Table 32. Global Supplement for Menopause Sales by Country/Region (2021-2026) & (K Units) Table 33. Global Supplement for Menopause Sales Market Share by Country/Region (2021-2026) Table 34. Global Supplement for Menopause Revenue by Country/Region (2021-2026) & ($ millions) Table 35. Global Supplement for Menopause Revenue Market Share by Country/Region (2021-2026) Table 36. Americas Supplement for Menopause Sales by Country (2021-2026) & (K Units) Table 37. Americas Supplement for Menopause Sales Market Share by Country (2021-2026) Table 38. Americas Supplement for Menopause Revenue by Country (2021-2026) & ($ millions) Table 39. Americas Supplement for Menopause Sales by Type (2021-2026) & (K Units) Table 40. Americas Supplement for Menopause Sales by Application (2021-2026) & (K Units) Table 41. APAC Supplement for Menopause Sales by Region (2021-2026) & (K Units) Table 42. APAC Supplement for Menopause Sales Market Share by Region (2021-2026) Table 43. APAC Supplement for Menopause Revenue by Region (2021-2026) & ($ millions) Table 44. APAC Supplement for Menopause Sales by Type (2021-2026) & (K Units) Table 45. APAC Supplement for Menopause Sales by Application (2021-2026) & (K Units) Table 46. Europe Supplement for Menopause Sales by Country (2021-2026) & (K Units) Table 47. Europe Supplement for Menopause Revenue by Country (2021-2026) & ($ millions) Table 48. Europe Supplement for Menopause Sales by Type (2021-2026) & (K Units) Table 49. Europe Supplement for Menopause Sales by Application (2021-2026) & (K Units) Table 50. Middle East & Africa Supplement for Menopause Sales by Country (2021-2026) & (K Units) Table 51. Middle East & Africa Supplement for Menopause Revenue Market Share by Country (2021-2026) Table 52. Middle East & Africa Supplement for Menopause Sales by Type (2021-2026) & (K Units) Table 53. Middle East & Africa Supplement for Menopause Sales by Application (2021-2026) & (K Units) Table 54. Key Market Drivers & Growth Opportunities of Supplement for Menopause Table 55. Key Market Challenges & Risks of Supplement for Menopause Table 56. Key Industry Trends of Supplement for Menopause Table 57. Supplement for Menopause Raw Material Table 58. Key Suppliers of Raw Materials Table 59. Supplement for Menopause Distributors List Table 60. Supplement for Menopause Customer List Table 61. Global Supplement for Menopause Sales Forecast by Region (2027-2032) & (K Units) Table 62. Global Supplement for Menopause Revenue Forecast by Region (2027-2032) & ($ millions) Table 63. Americas Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units) Table 64. Americas Supplement for Menopause Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 65. APAC Supplement for Menopause Sales Forecast by Region (2027-2032) & (K Units) Table 66. APAC Supplement for Menopause Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 67. Europe Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units) Table 68. Europe Supplement for Menopause Revenue Forecast by Country (2027-2032) & ($ millions) Table 69. Middle East & Africa Supplement for Menopause Sales Forecast by Country (2027-2032) & (K Units) Table 70. Middle East & Africa Supplement for Menopause Revenue Forecast by Country (2027-2032) & ($ millions) Table 71. Global Supplement for Menopause Sales Forecast by Type (2027-2032) & (K Units) Table 72. Global Supplement for Menopause Revenue Forecast by Type (2027-2032) & ($ millions) Table 73. Global Supplement for Menopause Sales Forecast by Application (2027-2032) & (K Units) Table 74. Global Supplement for Menopause Revenue Forecast by Application (2027-2032) & ($ millions) Table 75. AdvaCare Pharma Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 76. AdvaCare Pharma Supplement for Menopause Product Portfolios and Specifications Table 77. AdvaCare Pharma Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. AdvaCare Pharma Main Business Table 79. AdvaCare Pharma Latest Developments Table 80. Amerifit Brands (Estroven) Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 81. Amerifit Brands (Estroven) Supplement for Menopause Product Portfolios and Specifications Table 82. Amerifit Brands (Estroven) Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Amerifit Brands (Estroven) Main Business Table 84. Amerifit Brands (Estroven) Latest Developments Table 85. Biofarma Group Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 86. Biofarma Group Supplement for Menopause Product Portfolios and Specifications Table 87. Biofarma Group Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Biofarma Group Main Business Table 89. Biofarma Group Latest Developments Table 90. Bonafide Health Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 91. Bonafide Health Supplement for Menopause Product Portfolios and Specifications Table 92. Bonafide Health Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Bonafide Health Main Business Table 94. Bonafide Health Latest Developments Table 95. Equelle Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 96. Equelle Supplement for Menopause Product Portfolios and Specifications Table 97. Equelle Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Equelle Main Business Table 99. Equelle Latest Developments Table 100. Flourish Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 101. Flourish Supplement for Menopause Product Portfolios and Specifications Table 102. Flourish Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Flourish Main Business Table 104. Flourish Latest Developments Table 105. GNC Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 106. GNC Supplement for Menopause Product Portfolios and Specifications Table 107. GNC Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. GNC Main Business Table 109. GNC Latest Developments Table 110. Kobayashi Pharmaceutical Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 111. Kobayashi Pharmaceutical Supplement for Menopause Product Portfolios and Specifications Table 112. Kobayashi Pharmaceutical Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Kobayashi Pharmaceutical Main Business Table 114. Kobayashi Pharmaceutical Latest Developments Table 115. Makers Nutrition Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 116. Makers Nutrition Supplement for Menopause Product Portfolios and Specifications Table 117. Makers Nutrition Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Makers Nutrition Main Business Table 119. Makers Nutrition Latest Developments Table 120. Menoelle Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 121. Menoelle Supplement for Menopause Product Portfolios and Specifications Table 122. Menoelle Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Menoelle Main Business Table 124. Menoelle Latest Developments Table 125. MenoLabs Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 126. MenoLabs Supplement for Menopause Product Portfolios and Specifications Table 127. MenoLabs Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. MenoLabs Main Business Table 129. MenoLabs Latest Developments Table 130. Menopace Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 131. Menopace Supplement for Menopause Product Portfolios and Specifications Table 132. Menopace Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Menopace Main Business Table 134. Menopace Latest Developments Table 135. New Nordic Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 136. New Nordic Supplement for Menopause Product Portfolios and Specifications Table 137. New Nordic Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. New Nordic Main Business Table 139. New Nordic Latest Developments Table 140. Nordic Naturals Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 141. Nordic Naturals Supplement for Menopause Product Portfolios and Specifications Table 142. Nordic Naturals Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Nordic Naturals Main Business Table 144. Nordic Naturals Latest Developments Table 145. Otsuka Pharmaceutical Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 146. Otsuka Pharmaceutical Supplement for Menopause Product Portfolios and Specifications Table 147. Otsuka Pharmaceutical Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Otsuka Pharmaceutical Main Business Table 149. Otsuka Pharmaceutical Latest Developments Table 150. PharmaLinea Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 151. PharmaLinea Supplement for Menopause Product Portfolios and Specifications Table 152. PharmaLinea Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. PharmaLinea Main Business Table 154. PharmaLinea Latest Developments Table 155. PhytoLife Pharma Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 156. PhytoLife Pharma Supplement for Menopause Product Portfolios and Specifications Table 157. PhytoLife Pharma Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. PhytoLife Pharma Main Business Table 159. PhytoLife Pharma Latest Developments Table 160. Promensil Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 161. Promensil Supplement for Menopause Product Portfolios and Specifications Table 162. Promensil Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Promensil Main Business Table 164. Promensil Latest Developments Table 165. SMPNutra Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 166. SMPNutra Supplement for Menopause Product Portfolios and Specifications Table 167. SMPNutra Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. SMPNutra Main Business Table 169. SMPNutra Latest Developments Table 170. The Better Menopause Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 171. The Better Menopause Supplement for Menopause Product Portfolios and Specifications Table 172. The Better Menopause Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. The Better Menopause Main Business Table 174. The Better Menopause Latest Developments Table 175. Vitabiotics Basic Information, Supplement for Menopause Manufacturing Base, Sales Area and Its Competitors Table 176. Vitabiotics Supplement for Menopause Product Portfolios and Specifications Table 177. Vitabiotics Supplement for Menopause Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Vitabiotics Main Business Table 179. Vitabiotics Latest Developments List of Figures Figure 1. Picture of Supplement for Menopause Figure 2. Supplement for Menopause Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Supplement for Menopause Sales Growth Rate 2021-2032 (K Units) Figure 7. Global Supplement for Menopause Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Supplement for Menopause Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Supplement for Menopause Sales Market Share by Country/Region (2025) Figure 10. Supplement for Menopause Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of Hormone Regulation Supplements Figure 12. Product Picture of Bone Health Supplements Figure 13. Product Picture of Cardiovascular and Metabolic Support Supplements Figure 14. Product Picture of Mood and Sleep Regulation Supplements Figure 15. Product Picture of Others Figure 16. Global Supplement for Menopause Sales Market Share by Type in 2026 Figure 17. Global Supplement for Menopause Revenue Market Share by Type (2021-2026) Figure 18. Supplement for Menopause Consumed in Online Pharmacies Figure 19. Global Supplement for Menopause Market: Online Pharmacies (2021-2026) & (K Units) Figure 20. Supplement for Menopause Consumed in Retail Pharmacies Figure 21. Global Supplement for Menopause Market: Retail Pharmacies (2021-2026) & (K Units) Figure 22. Supplement for Menopause Consumed in Hospital Figure 23. Global Supplement for Menopause Market: Hospital (2021-2026) & (K Units) Figure 24. Global Supplement for Menopause Sale Market Share by Application (2025) Figure 25. Global Supplement for Menopause Revenue Market Share by Application in 2026 Figure 26. Supplement for Menopause Sales by Company in 2026 (K Units) Figure 27. Global Supplement for Menopause Sales Market Share by Company in 2026 Figure 28. Supplement for Menopause Revenue by Company in 2026 ($ millions) Figure 29. Global Supplement for Menopause Revenue Market Share by Company in 2026 Figure 30. Global Supplement for Menopause Sales Market Share by Geographic Region (2021-2026) Figure 31. Global Supplement for Menopause Revenue Market Share by Geographic Region in 2026 Figure 32. Americas Supplement for Menopause Sales 2021-2026 (K Units) Figure 33. Americas Supplement for Menopause Revenue 2021-2026 ($ millions) Figure 34. APAC Supplement for Menopause Sales 2021-2026 (K Units) Figure 35. APAC Supplement for Menopause Revenue 2021-2026 ($ millions) Figure 36. Europe Supplement for Menopause Sales 2021-2026 (K Units) Figure 37. Europe Supplement for Menopause Revenue 2021-2026 ($ millions) Figure 38. Middle East & Africa Supplement for Menopause Sales 2021-2026 (K Units) Figure 39. Middle East & Africa Supplement for Menopause Revenue 2021-2026 ($ millions) Figure 40. Americas Supplement for Menopause Sales Market Share by Country in 2026 Figure 41. Americas Supplement for Menopause Revenue Market Share by Country (2021-2026) Figure 42. Americas Supplement for Menopause Sales Market Share by Type (2021-2026) Figure 43. Americas Supplement for Menopause Sales Market Share by Application (2021-2026) Figure 44. United States Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 45. Canada Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 46. Mexico Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 47. Brazil Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 48. APAC Supplement for Menopause Sales Market Share by Region in 2026 Figure 49. APAC Supplement for Menopause Revenue Market Share by Region (2021-2026) Figure 50. APAC Supplement for Menopause Sales Market Share by Type (2021-2026) Figure 51. APAC Supplement for Menopause Sales Market Share by Application (2021-2026) Figure 52. China Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 53. Japan Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 54. South Korea Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 55. Southeast Asia Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 56. India Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 57. Australia Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 58. China Taiwan Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 59. Europe Supplement for Menopause Sales Market Share by Country in 2026 Figure 60. Europe Supplement for Menopause Revenue Market Share by Country (2021-2026) Figure 61. Europe Supplement for Menopause Sales Market Share by Type (2021-2026) Figure 62. Europe Supplement for Menopause Sales Market Share by Application (2021-2026) Figure 63. Germany Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 64. France Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 65. UK Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 66. Italy Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 67. Russia Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 68. Middle East & Africa Supplement for Menopause Sales Market Share by Country (2021-2026) Figure 69. Middle East & Africa Supplement for Menopause Sales Market Share by Type (2021-2026) Figure 70. Middle East & Africa Supplement for Menopause Sales Market Share by Application (2021-2026) Figure 71. Egypt Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 72. South Africa Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 73. Israel Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 74. Turkey Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 75. GCC Countries Supplement for Menopause Revenue Growth 2021-2026 ($ millions) Figure 76. Manufacturing Cost Structure Analysis of Supplement for Menopause in 2026 Figure 77. Manufacturing Process Analysis of Supplement for Menopause Figure 78. Industry Chain Structure of Supplement for Menopause Figure 79. Channels of Distribution Figure 80. Global Supplement for Menopause Sales Market Forecast by Region (2027-2032) Figure 81. Global Supplement for Menopause Revenue Market Share Forecast by Region (2027-2032) Figure 82. Global Supplement for Menopause Sales Market Share Forecast by Type (2027-2032) Figure 83. Global Supplement for Menopause Revenue Market Share Forecast by Type (2027-2032) Figure 84. Global Supplement for Menopause Sales Market Share Forecast by Application (2027-2032) Figure 85. Global Supplement for Menopause Revenue Market Share Forecast by Application (2027-2032)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の 医薬品・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（supplement）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
